Articles in Press [26 articles]

• Alzheimer’s Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in cut off levels from Thai experience, Vorapun Senanarong, Nopwan Siwasariyanon, Lertchai Washirutmangkur, Niphon Poungvarin, Chachawan Ratanabunakit, Natpapol Aoonkaew, and Suthopol Udomphanthurak
• Trends in the prevalence of dementia in Japan, Hiroko H. Dodge, Teresa Buracchio, Gwenith Fisher, Yutaka Kiyohara, Kenichi Meguro, Yumihiro Tanizaki, and Jeffrey A. Kaye
• Mild Cognitive Impairment: Beyond Memory Dysfunction, Andrea Tales, Anthony Bayer, Štefan Krajcík, and Kurt A. Jellinger
• Quantitative EEG markers in Mild Cognitive Impairment: degenerative versus vascular brain impairment., Davide V. Moretti, Giuliano Binetti, Orazio Zanetti, and Giovanni B. Frisoni
• Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment, JR Walton
• Relative preservation of advanced activities in daily living among patients with mild to moderate dementia in the community and overview of support provided by family caregivers, Hajime Takechi, Atsuko Kokuryu, Tomoko Kubota, and Hiroko Yamada
• Reliable measurements of the ß-amyloid pool in blood could help in the early diagnosis of AD., Pedro Pesini, Virginia Pérez-Grijalba, Inmaculada Monleón, Mercè Boada, Lluis Tárraga, Pablo Martínez-Lage, Itziar San-José, and Manuel Sarasa
• Microglia, Alzheimer’s disease and complement, Helen Crehan, John Hardy, and Jennifer Pocock
• Characterizing cognitive deficits and dementia in an aging urban population in India, Girish Nair, Kathleen Van Dyk, Urvashi Shah, Dushyant P. Purohit, Charles Pinto, Arun B. Shah, Hillel Grossman, Daniel Perl, Vaishali Ganwir, Shanti Shanker, and Mary Sano
• Chinese-Language Montreal Cognitive Assessment for Cantonese or Mandarin Speakers: Age, Education, and Gender Effects, Ling Zheng, Evelyn Teng, Rohit Varma, Wendy J. Mack, Dan M. Mungas, Po H. Lu, and Helena C. Chui
• Glycogen synthase kinase 3 (GSK3): a point of integration in Alzheimer’s disease and a therapeutic target?, Siddhartha Mondragon-Rodriguez, George Perry, Xiongwei W. Zhu, Paula I. Moreira, and Sylvain Williams
• Will Post-translational Modifications of Brain Proteins Provide Novel Serological Markers for Dementias?, Yaguo Wang, Mette Grøndahl Sørensen, Qinlong Zheng, Chen Zhang, Morten Asser Karsdal, and Kim Henriksen
• Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade, Huntington Potter and Thomas M. Wisniewski
• Is there inflammatory synergy in type II diabetes mellitus and Alzheimer’s disease?, Lih-Fen Lue, Cassandra Andrade, Marwan Sabbagh, and Douglas Gordon Walker
• Lessons from Tau-deficient Mice, Yazi D Ke, Alexandra Suchowerska, Julia van der Hoven, Dineeka M De Silva, Christopher W Wu, Janet van Eersel, Arne Ittner, and Lars M. Ittner
• MicroRNAs and the regulation of Tau metabolism, Sébastien S. Hébert, Nicolas Sergeant, and L. Buée
• Executive dysfunction in MCI: Subtype or early symptom, Ivar Reinvang, Ramune Grambaite, and Thomas Espeseth
• Microglia in Alzheimer disease: it’s all about context, Tara M. Weitz and Terrence Town
• Drosophila models of tauopathies: what have we learned?, Marc Gistelinck, Jean Charles Lambert, Patrick Callaerts, Bart Dermaut, and Pierre Dourlen
• Dementia and Diabetes Mellitus: association with ApolipoproteinE4 polymorphism from a hospital in Southern India., Lakshmi Narayanan Kota, Bhagyalakshmi Mallapura Shankarappa, Prafulla Shivakumar, Shilpa Sadanand, Bhavani Shankara Bagepally, Srinivas Brahmadevarahalli Krishnappa, Meera Purushottam, Palanimuthu Thangaraju Sivakumar, Sanjeev Jain, Mathew Varghese, and Srikala Bharath
• Tau and Caspase 3 as Targets for Neuroprotection, I. Gozes, Anat Idan- Feldman, and Regina Ostritsky
• Japanese Alzheimer’s disease and other complex disorders diagnosis based on mitochondrial SNP haplogroups, Takasaki Shigeru
• Structure and pathology of tau protein in Alzheimer disease, Kolarova Michala, Francisco García-Sierra, Bartos Ales, Ricny Jan, and Ripova Daniela
• Neuroprotection and Neuroregeneration in Alzheimer's Disease, Kiminobu Sugaya, K. S. Jagannatha Rao, Moussa B. H. Youdim, and Agneta Nordberg
• Protein Tau, prime cause of synaptic and neuronal degeneration in Alzheimer's disease, Natalia Crespo-Biel, Clara Theunis, and Fred Van Leuven
• Small-molecule inhibitors of GSK-3 - Structural insights and their application to Alzheimer´s disease models, Thomas Kramer, Boris Schmidt, and Fabio Lo Monte